UPDATED Apr 25, 2024
Potentially undervalued companies with a strong past performance and robust balance sheet.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$399.04 | -1.3% | 30.9% | US$3.0t | US$471.24 | PE35.9x | E12.6% | 0.8% | Software | ||
GOOGL | US$156.00 | -0.006% | 45.0% | US$2.0t | US$166.83 | PE26.3x | E11.9% | n/a | Media | ||
AMZN | US$173.67 | -3.1% | 58.1% | US$1.8t | US$210.59 | PE59.4x | E21.6% | n/a | Retail | ||
META | US$441.38 | -12.0% | 85.0% | US$1.1t | US$524.32 | PE24.5x | E12.3% | 0.5% | Media | ||
CRM | US$273.14 | 0.4% | 39.4% | US$264.9b | US$336.10 | PE64.1x | E18.7% | 0.6% | Software | ||
ADBE | US$473.44 | 0.05% | 27.5% | US$212.1b | US$617.38 | PE44.2x | E17.1% | n/a | Software | ||
PDD | US$125.79 | 10.6% | 90.2% | US$174.7b | US$179.67 | PE21.1x | E23.0% | n/a | Retail | ||
AXP | US$237.10 | 9.0% | 49.6% | US$170.5b | US$223.21 | PE19.2x | E7.5% | 1.2% | Diversified Financials | ||
VRTX | US$397.70 | 1.1% | 17.2% | US$102.8b | US$460.34 | PE28.4x | E11.5% | n/a | Pharmaceuticals & Biotech | ||
CRWD | US$298.02 | 1.3% | 136.4% | US$72.1b | US$390.62 | PE806.9x | E34.6% | n/a | Software | ||
SLB | US$49.44 | -2.9% | 3.1% | US$70.7b | US$67.11 | PE16.3x | E13.1% | 2.2% | Energy | ||
NTES | US$94.12 | 1.8% | 6.3% | US$60.7b | US$132.85 | PE14.9x | E7.9% | 2.7% | Media | ||
HWM | US$64.80 | 2.0% | 48.2% | US$26.5b | US$71.65 | PE34.7x | E14.8% | 0.3% | Capital Goods | ||
LI | US$23.47 | -19.6% | 1.0% | US$24.9b | US$50.12 | PE15.4x | E22.0% | n/a | Automobiles | ||
KSPI | US$116.32 | 3.6% | 48.8% | US$22.0b | US$151.25 | PE11x | E17.4% | 6.6% | Diversified Financials | ||
MOH | US$352.30 | -2.4% | 18.7% | US$20.6b | US$416.19 | PE19.3x | E17.1% | n/a | Healthcare | ||
LYV | US$88.49 | -1.3% | 31.4% | US$20.3b | US$117.74 | PE64.3x | E22.5% | n/a | Media | ||
BMRN | US$82.17 | -8.8% | -11.1% | US$15.6b | US$109.74 | PE75.9x | E29.8% | n/a | Pharmaceuticals & Biotech | ||
DT | US$46.60 | 0.7% | 9.8% | US$13.8b | US$62.35 | PE70x | E18.6% | n/a | Software | ||
HTHT | US$39.74 | 6.4% | -12.8% | US$12.5b | US$52.39 | PE22.1x | E10.7% | 3.1% | Consumer Services | ||
INCY | US$51.18 | -3.1% | -30.5% | US$11.5b | US$75.20 | PE19.2x | E18.8% | n/a | Pharmaceuticals & Biotech | ||
PAYC | US$186.58 | 0.9% | -35.4% | US$10.7b | US$204.00 | PE31.3x | E10.8% | 0.8% | Commercial Services | ||
DOX | US$85.64 | 0.6% | -5.5% | US$10.0b | US$104.90 | PE17.8x | E15.8% | 2.2% | Software | ||
PCTY | US$156.58 | -0.6% | -17.8% | US$8.8b | US$193.33 | PE52.7x | E17.4% | n/a | Commercial Services |